Shilpa Medicare Limited has announced its financial results for the quarter and financial year ended March 31, 2026. The company posted a significant increase in annual consolidated net profit to ₹24,333 lakh and recommended a final dividend of 60% (Re. 0.60 per share). Additionally, the company is shifting its registered office to Maharashtra and has announced a 28% equity investment in Neo Green Power Private Limited to secure captive renewable energy.
Financial Performance Overview
For the financial year ended March 31, 2026, Shilpa Medicare Limited reported a strong performance with consolidated revenue from operations reaching ₹153,887 lakh, compared to ₹128,643 lakh in the previous year. The annual consolidated net profit attributable to the company rose to ₹24,333 lakh, reflecting improved operational efficiency and business growth. The company’s Board has recommended a final dividend of Re. 0.60 per equity share of face value Re. 1/- for the fiscal year.
Strategic Renewable Energy Investment
In a move to optimize operational costs and enhance sustainability, the company’s wholly-owned subsidiaries—Shilpa Pharma Lifesciences Limited, Shilpa Biologicals Private Limited, and Shilpa Biocare Private Limited—are collectively acquiring a 28% equity stake in Neo Green Power Private Limited. The group contribution for this investment stands at ₹4.44 crore. This acquisition is primarily intended to meet the captive power consumption requirements of the company’s manufacturing units.
Corporate Restructuring and Governance
The company is undergoing significant administrative restructuring, including the shifting of its registered office from the state of Karnataka to the state of Maharashtra. This change, which also applies to its subsidiaries—Shilpa Pharma Lifesciences, Shilpa Biologicals, Shilpa Biocare, and Sampra Holdings—is subject to member approval via a postal ballot. To ensure transparent governance, the company has appointed M/s. V.J.Talati & Co. as Cost Auditors and M/s ANEJA ASSOCIATES as Internal Auditors for the FY 2026-27.
Source: BSE
